← Back to headlines
AstraZeneca and Daiichi Sankyo Secure EU Approval for Breast Cancer Drug Datroway
AstraZeneca and Daiichi Sankyo have received label expansion approval from the European Union for their drug Datroway, to be used in the treatment of breast cancer.
31 Jul, 10:53 — 31 Jul, 10:53
Sources
Showing 1 of 1 sources
